본문 바로가기
KERD
논문KCI 등재

Effects of Mix-1 on Anti-CD40 Antibody and Recombinant IL4- Induced Cytokine Production and Immunoglobulin E in Highly Purified Mouse B Cells

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

In the oriental medicine, a mixture of herbs has been commonly used as important components to control allergic and inflammatory diseases. In the present study, we prepared a mixture of Dictamni Radicis Cortex(Baiksunpee), Houttuyniae Herba(Uhsungcho), and Aurantii Immaturus Fructus(Jisil) to examine its anti-allergic effects in activated mouse splenic cells and found that Mix-1 is involved in regulating levels of B cell activating factors (CD23 and CD11a), IL-1β, IL-6, IL-10, TNF-α, and IgE as well as HRF expression. It was observed that Mix-1 did not have cytotoxic effects on mLFC. Mix-1 showed inhibition of CD23 and CD11 alpaha expression in mouse B cells, and also decreased the production of IL-6, TNF-α, and IgE. Both RT-PCR and ELISA analyses indicated that IL-6 and TNF alpha production were regulated at the gene expression level. In contrast, IL-10 mRNA and protein levels were increased in activated B cells by Mix-1 treatment. We also found that Mix-1 inhibited B cell proliferation and inhibited histamine releasing factor(HRF) expression, suggesting its inhibitory effect on histamine secretion. These data indicated that Mix-1 has an anti-allergic effect in activated macrophages and further suggest the possible application of Mix-1 as a therapeutic agent for the treatment of allergy-related diseases.

Abstract

In the oriental medicine, a mixture of herbs has been commonly used as important components to control allergic and inflammatory diseases. In the present study, we prepared a mixture of Dictamni Radicis Cortex(Baiksunpee), Houttuyniae Herba(Uhsungcho), and Aurantii Immaturus Fructus(Jisil) to examine its anti-allergic effects in activated mouse splenic cells and found that Mix-1 is involved in regulating levels of B cell activating factors (CD23 and CD11a), IL-1β, IL-6, IL-10, TNF-α, and IgE as well as HRF expression. It was observed that Mix-1 did not have cytotoxic effects on mLFC. Mix-1 showed inhibition of CD23 and CD11 alpaha expression in mouse B cells, and also decreased the production of IL-6, TNF-α, and IgE. Both RT-PCR and ELISA analyses indicated that IL-6 and TNF alpha production were regulated at the gene expression level. In contrast, IL-10 mRNA and protein levels were increased in activated B cells by Mix-1 treatment. We also found that Mix-1 inhibited B cell proliferation and inhibited histamine releasing factor(HRF) expression, suggesting its inhibitory effect on histamine secretion. These data indicated that Mix-1 has an anti-allergic effect in activated macrophages and further suggest the possible application of Mix-1 as a therapeutic agent for the treatment of allergy-related diseases.

참고문헌 (55)

  1. "Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects", j immu(l 151), pp.3853~65 (1993)
  2. "Results of a phase I trial with SCH55700", pp.~2000
  3. "and lung damage in a mouse asthma model"
  4. "Effects of anti-IL-5 monoclonal antibody on the murine model of nasal allergy", pp.49~52 (1998)
  5. "Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation", pp.787~52 94 (1993)
  6. "Involvement of IL-5 in a murine model of allergic pulmonary inflammation prophylactic and therapeutic effect of an anti-IL-5 antibody", pp.360~5 (1995)
  7. "Pharmacokinetics and pharmacodynamics of SB-240563 a humanized monoclonal antibody directed to human interleukin-5 in monkeys", pp.1060~7 (1999), Benincosa LJ Hottenstein CS Tobia LA et al
  8. "Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs", pp.548~52 (1993)
  9. "Therapeutic potential of anti-IgE antibadies Curr Opinion in Immunology 9", pp.805~1997
  10. "IgE-mediated hypersensitivity against human sweat antigen in patients withatopic dermatitis", pp.335~40 (2002)
  11. "IgE binding factors and regulation of the IgE antibady response", annu rev immu(l 6) (1998)
  12. "Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells and mast cells in bronchial biopsies obtained from atopic andnonatopic", eosi j immu(phils l), pp.3539~1 44 (1997)
  13. "Complex role of the IL-4 receptor alpha in a murine model of airwayinflammation expression of the IL-4 receptor alpha on nonlymphoid cells of bonemarrow origin contributes to severity of inflammation", j immu(ben-trauth n l), pp.4545~1 55 (2004)
  14. "Mechanism of topical glucocorticoid treatment of hay fever IL-5 and eosinophilactivation during natural allergen exposure are suppressed", pp.521~6 9 (2000)
  15. "neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma comparison with iopsy specimens from atopic subjects witout asthma and normal control subjects and relationship to bronchial hyperrespon siveness", eosi(phils), pp.661~74 (1991)
  16. "Reciprocal regulatory effects of IFNg and IL-4 on the in vitro development of human Th1 and Th2 clones", immu(l 148), pp.2142~7 (1992)
  17. "Biology and therapeutic potential of the interleukin-4", interleukin-13 signalingpathway in asthma, 2002, pp.1(3), 185~93
  18. "de Vries JE IgE production by normal human lymphocytes is induced by interleukin-4 and suppressed by interferons-α and -γ and prostaglandin E2" (1998)
  19. "Roles of interleukin-13 and interferon-gamma in lung inflammation", pp.3~ (2002)
  20. "Selective induction of intercellular adhesion molecule-1 by interferon-g in human airway epithelial cells" (1992)
  21. "Anti-proliferative effect of IFN- gamma in immune regulation IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones", immu(l) (1988)
  22. "Effects of substance P and vasoactive intestinal peptide on interferon-gammaand interleukin-4 production in severe atopic dermatitis", pp.227~32 (2000)
  23. "Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 productionand airway hyperresponsiveness in allergic mice", pp.2 676~81 (2000)
  24. "Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulationof their pool size by IL-4", eur j immu(l), pp.413~23 (2002)
  25. "Gelfand EW Nebulized IFN-γ inhibits the development of secondary allergic responses in mice", j immu(l 157) (1996)
  26. "Relationships among numbers of bronchoalveolar lavage cells expressing mRNA for cytokines and airway methacholine responsiveness in atopic asthma", pp.397~403 (2002)
  27. "Detection of spontaneous and antigen-induced human interleukin-4 responses invitro comparison of ELISPOT", j immu(l methods), pp.1 55~1 2 67 (2002)
  28. "Reduced interferon-γ secretion in neonates and subsequent atopy", pp.~344 (1994)
  29. "Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes", pp.2098~101 (2001)
  30. "Synthetic IgE peptide vaccine for immunotherapy of allergy", pp.1580~2 90 (2003)
  31. "Regulation of interleukin 4 gene transcription alterations in atopic disease", pp.3~5 (2000)
  32. "Biology of interleukin-5 and its relevance to allergic disease", pp.71~51 81 (1996)
  33. "Effects of interleukin-5 blocking monoclonal antibody on eosinophils", pp.2144~8 (2000)
  34. "Inhibitory effects of anti-asthmatic material on the proinflammatory cytokine" (1999), A thesis for the degree of master of science
  35. "Sophoricoside analogs as the IL-5 inhibitors from Sophora japonica", pp.408~12 (1999)
  36. "The Chinese hebal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates Th1", Th2 response in a murine model of allergic asthma, 2000, 660~8
  37. "Effect of benzopyrone derivatives on simultaneously induced croton oil ear and carrageenin paw edema in rats"
  38. "The relationship between development of lung inflammation and changes in bone marrow populations in guinea pigs following inhaled antigen challenge", pp.1~11 (1991)
  39. "Leukocyte kinesis in blood bronchoalveoli and nasal cavities during late asthmatic responses in guinea-pigs", koh(s), pp.636~42 (1998)
  40. "a heterogeneous group of different activities", pp.1175~82 (2003)
  41. "Human IL-10 reduces the number of IL-4-induced IgE B cells in cultures ofatopic mononuclear cells", pp.26~31 (1994)
  42. "and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression", pp.915~10 10 924 (1991)
  43. "Inhibition of Langerhans cell antigen-presenting function by IL-10 a role for IL-10 in induction of tolerance", immu(l), pp.2390~2398 (1993)
  44. "Interleukin-10 regulation in normal and asthmatic subjects", immu(l), pp.1288~1296 (1996), Aarons
  45. "Maintenance of clonal anergy by endogenously produced IL-10", immu(l), pp.1605~1612 (1994)
  46. "which is downregulated in cystic fibrosis", (rmal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10), pp.257~261 (1995)
  47. "Interleukin 10 inhibits lipopoly- saccharide induced survival and cytokine production by human peripheral blood eosinophils", pp.711~715 (1994)
  48. "Induction of antigen-specific IgE response in murine lymphocytes by IL-10", immu(l), pp.127~132 (1995)
  49. "Overexpression of IL-10 in atopic dermatitis contrasting cytokine patterns with delayed-type hypersensitivity reactions", immu(l) (1956)
  50. "IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes", pun immu(nen l), pp.1280~1289 (1993)
  51. "Increased expression of the interleukin 10 gene in alveolar macrophages in interstitial lung diseases", pp.~683 (1997)
  52. "Human IL-10 is produced by both type 1 helper", immu(l), pp.353~360 (1993)
  53. "Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis", pp.1089~1099 (1997)
  54. "Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes" (1890)
  55. "B cells to secrete IgG1 and IgG3", pp.757~762 (1994)

관련 논문AI추천

이 간행물의 다른 논문 (32건)